In recent years, you may have seen headlines like: “Weight-loss or diabetes drug may reduce dementia risk.” The drugs in question are GLP-1 receptor agonists (GLP-1 RAs) such as Semaglutide (Ozempic/Wegovy), Liraglutide (Victoza/Saxenda), and others. But is the idea that…
- Phone: +1 (817) 735-2963
- 855 Montgomery St., 5th floor, Fort Worth, Texas, 76107


